CD4 and neoplasm: In metastatic colorectal cancer, this subpopulation has been found to favor immunosuppression and tumor growth (53) while in urological cancer it is correlated with differentiation of CD4+ naïve T cells to the pro-tumoral Th2 phenotype (54).